Written answers

Tuesday, 26 September 2023

Department of Health

Cannabis for Medicinal Use

Photo of Gino KennyGino Kenny (Dublin Mid West, People Before Profit Alliance)
Link to this: Individually | In context | Oireachtas source

572. To ask the Minister for Health when the clinical review of the future of the medical cannabis access programme will be finalised; and if he will make a statement on the matter. [41391/23]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

It is anticipated the review of the Medical Cannabis Access Programme, to ascertain if evidence exists to broaden the scope of conditions covered by the programme, will be completed by the end of 2023.

Photo of Gino KennyGino Kenny (Dublin Mid West, People Before Profit Alliance)
Link to this: Individually | In context | Oireachtas source

573. To ask the Minister for Health how many patients to date have been enrolled in the medical cannabis access programme; if he will provide a breakdown, on those enrolments, of the conditions for which they have been prescribed; and if he will make a statement on the matter. [41392/23]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Since its commencement, 49 patients have been accepted for treatment with cannabis based products for the treatment of one the stated conditions in the programme, namely:

a. Spasticity associated with multiple sclerosis resistant to all standard therapies and interventions whilst under expert medical supervision; 34 patients

b. Intractable nausea and vomiting associated with chemotherapy, despite the use of standard anti-emetic regimes whilst under expert medical supervision; 3 patients

c. Severe, refractory (treatment-resistant) epilepsy that has failed to respond to standard anticonvulsant medications whilst under expert medical supervision: 12 patients

Comments

No comments

Log in or join to post a public comment.